These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 21590188)
1. Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolization. Colleoni M; Liessi G; Mastrapasqua G; Boni L; Nelli P; Vicario G; Sgarbossa G; Pancheri F; Manente P Oncol Rep; 1997; 4(5):1025-8. PubMed ID: 21590188 [TBL] [Abstract][Full Text] [Related]
2. Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinoma. Colleoni M; Vicario G; Manente P; De Braud F; Fazio N; Liessi G Tumori; 1998; 84(6):673-6. PubMed ID: 10080675 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of intra-arterial chemotherapy followed by chemoembolization, every 28 days, in unresectable hepatocellular carcinoma. Colleoni M; Liessi G; Mastrapasqua G; Nelli P; Vicario G; Sgarbossa G; Pancheri F; Manente P Oncol Rep; 1996 Sep; 3(5):879-82. PubMed ID: 21594473 [TBL] [Abstract][Full Text] [Related]
4. Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinoma. Colleoni M; Liessi G; Mastrapasqua G; Nelli P; Vicario G; Sgarbossa G; Pancheri F; Manente P Eur J Cancer; 1997 Jan; 33(1):56-60. PubMed ID: 9071900 [TBL] [Abstract][Full Text] [Related]
5. Arterial chemoembolization with epirubicin in unresectable hepatocellular-carcinoma in cirrhosis. Colleoni M; Gaion F; Liessi G; Mastropasqua G; Nelli P Oncol Rep; 1994 Nov; 1(6):1171-5. PubMed ID: 21607510 [TBL] [Abstract][Full Text] [Related]
6. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?]. Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951 [TBL] [Abstract][Full Text] [Related]
7. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429 [TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766 [TBL] [Abstract][Full Text] [Related]
9. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Chung JW; Park JH; Han JK; Choi BI; Han MC AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Uraki J; Yamakado K; Nakatsuka A; Takeda K Eur J Radiol; 2004 Jul; 51(1):12-8. PubMed ID: 15186879 [TBL] [Abstract][Full Text] [Related]
12. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075 [TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles. Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma. Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344 [TBL] [Abstract][Full Text] [Related]
17. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire N Engl J Med; 1995 May; 332(19):1256-61. PubMed ID: 7708069 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248 [TBL] [Abstract][Full Text] [Related]
19. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial. Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720 [TBL] [Abstract][Full Text] [Related]
20. [The treatment of hepatocellular carcinoma by chemoembolization]. Marchiori L; Mansueto GC; Nifosi F; Bortolasi L; Dal Dosso I; Facci E; Perus G; Nicoli N Chir Ital; 1994; 46(1):17-22. PubMed ID: 8025966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]